Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (21.864)
1
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer : A Phase 3, randomized, open label study of lorlatinib (PF 06463922) monotherapy versus crizotinib monotherapy in the first line treatment of patients with advanced ALK positive non small cell lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC) : An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A trial to evaluate the safety of long term treatment withnintedanib in patients with scleroderma related lung fibrosis. : An open-label extension trial to assess the long term safety ofnintedanib in patients with ‘Systemic Sclerosis associatedInterstitial Lung Disease’ (SSc-ILD) - SENSCIS(R) -ON
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A randomized, open-label, multicenter study comparing the efficacy, safety and tolerability of rovalpituzumab tesirine versus topotecan for DLL3high SCLC subjects with first relapse/recurrence following front-line platinum-based chemotherapy. : A Randomized, Open-Label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared with Topotecan for Subjects with Advanced or Metastatic DLL3high Small Cell Lung Cancer (SCLC) who have First Disease Progression During or Following Front-Line Platinum-Based Chemotherapy (TAHOE) - TAHOE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study to evaluate the safety and efficacy of CC-90011 in combination with nivolumab in subjects with advanced cancers. : A Phase 2, multicenter, open-label, multi-cohort study to assess safety and efficacy of CC-90011 in combination with nivolumab in subjects with advanced cancers.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A dose escalation trial to assess the safety and tolerability of multiple doses of the CAN04 antibody, in patients with solid malignant tumors. : An open label, dose escalation followed by dose expansion, safety and tolerability trial of CAN04, a fully humanized monoclonal antibody against IL1RAP, in subjects with solid malignant tumors - CANFOUR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Study of ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer : A Phase 1b/2 Study of the Dual MDMX/MDM2 Inhibitor, ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A randomized, open-label, multicenter study comparing the efficacy, safety and tolerability of rovalpituzumab tesirine versus topotecan for DLL3high SCLC subjects with first relapse/recurrence following front-line platinum-based chemotherapy. : A Randomized, Open-Label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared with Topotecan for Subjects with Advanced or Metastatic DLL3high Small Cell Lung Cancer (SCLC) who have First Disease Progression During or Following Front-Line Platinum-Based Chemotherapy (TAHOE) - TAHOE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU) : A Randomized, Double-Blind, Placebo-Controlled Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung Cancer : A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Subjects with Advanced Non-small Cell Lung Cancer(Master Protocol Revised version 02 dated 27-Jul-2016 + Sub-protocol 01 Revised version 01 dated 08-Apr-2016) - FRACTION-Lung
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2187]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
21.864
Aufsätze
21.864
E-Artikel
21.864
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
21.864
610
17.762
Study Type: Interventional
8.778
Recruitment Status: Not yet recruiting
4.472
Recruitment Status: Recruiting
4.036
Phase: Phase 3
3.800
Phase: Phase 2
3.478
Recruitment Status: Authorised-recruitment may ...
3.278
Study Type: Observational
2.364
Recruitment Status: Complete: follow-up complete
1.778
Recruitment Status: Completed
1.152
Phase: Phase 1
982
Medical Condition: lung cancer
860
Medical Condition: Non-small cell lung cancer
702
Medical Condition: Lung cancer
534
Medical Condition: non-small cell lung cancer
502
Recruitment Status: Complete: follow-up continuing
408
Medical Condition: Lung Cancer
390
Phase: Phase 4
386
Phase: Other
356
Study Type: Diagnostic test
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
14.394
2020-
7.470
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
21.452
Englisch
248
Unbestimmt
90
Spanisch
26
Niederländisch
20
Französisch
14
Deutsch
4
Italienisch
2
Dänisch
2
Indonesisch
2
Norwegisch
2
Slowakisch
2
Slowenisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...